Literature DB >> 24634379

Emerging immunologic biomarkers: setting the (TNM-immune) stage.

Janis M Taube1.   

Abstract

The cooperation of tumor-infiltrating lymphocytes and tertiary lymphoid tissue in early-stage colorectal carcinoma further corroborates the strong immune influences on tumor progression and patient outcome. Immune factors in the tumor microenvironment may warrant inclusion in pathology reports and staging systems for prognostication and prediction of therapeutic response. ©2014 AACR.

Entities:  

Mesh：

Year:  2014        PMID： 24634379      PMCID： PMC4036638          DOI： 10.1158/1078-0432.CCR-14-0328

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  11 in total

1.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

2.  Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Authors:  Nancy E Thomas; Klaus J Busam; Lynn From; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Pamela A Groben; Honglin Hao; Irene Orlow; Anne S Reiner; Li Luo; Susan Paine; David W Ollila; Homer Wilcox; Colin B Begg; Marianne Berwick
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

Review 3.  Natural immunity to cancer in humans.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  Curr Opin Immunol       Date:  2010-03-06       Impact factor: 7.486

4.  Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.

Authors:  Janis M Taube; Robert A Anders; Geoffrey D Young; Haiying Xu; Rajni Sharma; Tracee L McMiller; Shuming Chen; Alison P Klein; Drew M Pardoll; Suzanne L Topalian; Lieping Chen
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

5.  Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.

Authors:  Luc de Chaisemartin; Jérémy Goc; Diane Damotte; Pierre Validire; Pierre Magdeleinat; Marco Alifano; Isabelle Cremer; Wolf-Herman Fridman; Catherine Sautès-Fridman; Marie-Caroline Dieu-Nosjean
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

Review 6.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

7.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

Review 8.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

Review 9.  Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

Authors:  Jérôme Galon; Bernhard Mlecnik; Gabriela Bindea; Helen K Angell; Anne Berger; Christine Lagorce; Alessandro Lugli; Inti Zlobec; Arndt Hartmann; Carlo Bifulco; Iris D Nagtegaal; Richard Palmqvist; Giuseppe V Masucci; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Michele Maio; Luigi Laghi; Fabio Grizzi; Martin Asslaber; Corrado D'Arrigo; Fernando Vidal-Vanaclocha; Eva Zavadova; Lotfi Chouchane; Pamela S Ohashi; Sara Hafezi-Bakhtiari; Bradly G Wouters; Michael Roehrl; Linh Nguyen; Yutaka Kawakami; Shoichi Hazama; Kiyotaka Okuno; Shuji Ogino; Peter Gibbs; Paul Waring; Noriyuki Sato; Toshihiko Torigoe; Kyogo Itoh; Prabhu S Patel; Shilin N Shukla; Yili Wang; Scott Kopetz; Frank A Sinicrope; Viorel Scripcariu; Paolo A Ascierto; Francesco M Marincola; Bernard A Fox; Franck Pagès
Journal:  J Pathol       Date:  2014-01       Impact factor: 7.996

10.  The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.

Authors:  Paolo A Ascierto; Mariaelena Capone; Walter J Urba; Carlo B Bifulco; Gerardo Botti; Alessandro Lugli; Francesco M Marincola; Gennaro Ciliberto; Jérôme Galon; Bernard A Fox
Journal:  J Transl Med       Date:  2013-03-03       Impact factor: 5.531
View more
  12 in total

1.  Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.

Authors:  Janis M Taube; Alison Klein; Julie R Brahmer; Haiying Xu; Xiaoyu Pan; Jung H Kim; Lieping Chen; Drew M Pardoll; Suzanne L Topalian; Robert A Anders
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

Review 2.  Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.

Authors:  Amer Assal; Justin Kaner; Gopichand Pendurti; Xingxing Zang
Journal:  Immunotherapy       Date:  2015-11-16       Impact factor: 4.196

Review 3.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.

Authors:  Suzanne L Topalian; Janis M Taube; Robert A Anders; Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

4.  Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model.

Authors:  Erika Elgström; Sophie E Eriksson; Otto Ljungberg; Pär-Ola Bendahl; Tomas G Ohlsson; Rune Nilsson; Jan Tennvall
Journal:  EJNMMI Res       Date:  2015-09-15       Impact factor: 3.138

5.  A four-factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma.

Authors:  Ming-Xiang Zou; Yue Pan; Wei Huang; Tao-Lan Zhang; David Escobar; Xiao-Bin Wang; Yi Jiang; Xiao-Ling She; Guo-Hua Lv; Jing Li
Journal:  Clin Transl Med       Date:  2020-01

6.  An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC).

Authors:  Haoyue Guo; Binglei Li; Li Diao; Hao Wang; Peixin Chen; Minlin Jiang; Lishu Zhao; Yayi He; Caicun Zhou
Journal:  Oncoimmunology       Date:  2021-07-13       Impact factor: 8.110

7.  Tertiary lymphoid tissue: A gateway for T cells in the tumor microenvironment.

Authors:  Giuseppe Di Caro; Federica Marchesi
Journal:  Oncoimmunology       Date:  2014-05-15       Impact factor: 8.110

8.  Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse.

Authors:  Roxana Khazen; Sabina Müller; Nicolas Gaudenzio; Eric Espinosa; Marie-Pierre Puissegur; Salvatore Valitutti
Journal:  Nat Commun       Date:  2016-03-04       Impact factor: 14.919

9.  The predictive value of centre tumour CD8⁺ T cells in patients with hepatocellular carcinoma: comparison with Immunoscore.

Authors:  Cheng Sun; Jing Xu; Jiaxi Song; ChaoQun Liu; Jinyu Wang; Chenchun Weng; Haoyu Sun; Haiming Wei; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Oncotarget       Date:  2015-11-03

10.  Association of cytotoxic T lymphocyte-associated protein 4 gene -1772T/C polymorphism with gastric cancer risk: A prisma-compliant meta-analysis.

Authors:  Chenyi Zhuo; Tingzhuang Yi; Cheng Wei; Xianjian Wu; Xiaoning Cen; Shi Feng; Xiqiang Tang; Yang Zhou; Qianli Tang
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.